NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-188-2021-0-PCT-02 ANTI-CMPL DIVALENT SCFV AND USES THEREOF PCT PCT PCT/US22/77326 Expired
NIBIB E-006-2020-0-US-03 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY US National Stage 17/995,271 Abandoned
NCI E-055-2017-0-HK-12 Combination Therapy of Immunotoxin and Checkpoint Inhibitor HK EP 42022061535.5 Pending
NIDA E-208-2022-0-US-01 Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders US 63/377,893 Expired
NCATS E-204-2022-1-US-01 MULTI-CYCLC IRAK1 AND IRAK4 INHIBITING COMPOUNDS AND USES THEREOF US 63/377,812 Expired
NICHD E-185-2021-0-PCT-02 CYCLIC PEPTIDES AS NON-HORMONAL MALE CONTRACEPTIVE AGENTS AND METHODS OF USE THEREOF PCT PCT PCT/US2022/077278 Expired
NIAAA E-282-2012-0-US-17 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US CON 17/956,313 Abandoned
NCI E-230-2012-0-US-82 T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 US CON 17/936,006 12404317 Issued PDF
NIAID E-081-2013-4-KR-23 Prefusion RSV F Proteins And Their Use KR DIV 10-2022-7033808 Issued
NCI E-061-2020-0-AU-03 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY AU National Stage 2021237717 Pending
NHLBI E-223-2022-0-US-01 Physiological Navigation In MRI Using Inherent Slab-selective Free-induction-decay Signal US 63/411,055 Expired
NCI E-494-2013-0-EP-30 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP DIV 22197914.9 Issued
NCI E-494-2013-0-GB-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells GB EP 22197914.9 Issued
NCI E-494-2013-0-ES-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells ES EP 22197914.9 Issued
NCI E-282-2016-2-US-01 Methods For Pre-conditioning Patients For Cell Therapy US CON 17/954,070 Pending
NCI E-103-2019-0-HK-16 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE HK CN 62022061195.3 Pending
NIAID E-236-2018-0-US-01 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof US DIV 17/952,308 Pending
NIAID E-097-2020-0-US-02 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE US National Stage 17/914,027 Pending
NCI E-088-2020-0-EP-07 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION EP National Stage 21712694.5 Pending
NCI E-088-2020-0-KR-10 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION KR National Stage 10-2022-7033222 Pending
NCI E-102-2020-0-AU-03 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY AU National Stage 2021239379 Pending
NIAID E-212-2022-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 63/409,016 Expired
NCI E-165-2021-0-PCT-02 FIBP Knockout In T Cells Amplifies Antitumor Activity By Limiting Cholesterol Metabolism, Suggesting A Potentiator Of Adoptive Cell Therapy PCT PCT PCT/US2022/076809 Expired
NCI E-059-2013-0-AU-24 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor AU DIV 2022235535 Issued
NCI E-075-2020-0-AU-03 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES AU National Stage 2021236049 Pending
NLM E-111-2016-7-EP-10 Novel CRISPR Enzymes And Systems EP DIV 22196333.3 Pending
NCI E-102-2020-0-IL-10 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY IL National Stage 296608 Pending
NCI E-061-2020-0-IL-10 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY IL National Stage 296629 Pending
NIAID E-086-2018-3-US-05 Zika Viral Antigen Constructs US CON 17/946,383 Abandoned
NCI E-102-2020-0-US-09 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US National Stage 17/906,524 Pending
NCI E-061-2020-0-US-09 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US National Stage 17/912,315 Pending
NCI E-102-2020-0-JP-07 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY JP National Stage 2022-556460 Pending
NCI E-061-2020-0-JP-07 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY JP National Stage 2022-556459 Abandoned
NIAID E-131-2020-7-IN-21 Anti-Coronavirus Antibodies And Methods Of Use IN National Stage 202217053137 Pending
NCI E-176-2014-0-KR-66 Anti-Human Papillomavirus 16 E7 T Cell Receptors KR DIV 10-2022-7032043 Issued
NCI E-088-2020-0-IN-08 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION IN National Stage 202247052620 Pending
NCI E-210-2018-1-PCT-02 Chimeric adaptor and kinase signaling proteins and their use in immunotherapy PCT PCT PCT/US2022/076358 Expired
NCI E-074-2020-1-EP-06 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION EP National Stage 21710740.8 Pending
NCI E-102-2020-0-CA-04 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CA National Stage 3171583 Pending
NCI E-061-2020-0-CA-04 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CA National Stage 3171559 Pending
NCI E-074-2020-1-KR-09 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION KR National Stage 10-2022-7031589 Pending
NCCIH E-081-2020-0-KR-01 MARGARIC ACID DECREASES PIEZO2-MEDIATED MEDIATED PAIN KR National Stage 10-2022-7031665 Pending
NCI E-239-2017-0-US-20 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US DIV 17/931,391 Pending
NCATS E-176-2018-0-KR-05 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF KR National Stage 10-2022-7030361 Pending
NCI E-150-2017-2-AU-01 Diagnostic Methods For T Cell Therapy AU DIV 2022231653 Pending
NCI E-075-2020-0-CA-04 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES CA National Stage 3171412 Pending
NIAID E-297-2016-2-JP-10 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES JP DIV 2022-144109 Issued
NCATS E-172-2021-0-PCT-02 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES PCT PCT PCT/US2022/076221 Expired
NIAID E-131-2020-7-JP-01 Anti-Coronavirus Antibodies And Methods Of Use JP National Stage 2022-554810 Pending
NEI E-194-2021-0-PCT-02 Systems and Methods to Automatically Detect Ellipsoid Zone Loss in SD-OCT Imaging PCT PCT PCT/US2022/076135 Expired